Standard Test Method for Analysis of Hemolytic Properties of Nanoparticles
Importancia y uso:
5.1 This test method is one of a series of tests listed in Practice F748 and ISO 10993-4 to assess the biocompatibility of materials contacting blood in medical applications.
5.2 This test method is similar to Practice F756 but modified to accommodate nanoparticulate materials.
Subcomité:
E56.03
Referida por:
F0756-17
Volúmen:
14.02
Número ICS:
11.100.01 (Laboratory medicine in general)
Palabras clave:
hemolysis; nanoparticulate; plasma; whole blood;
$ 1,086
Norma
E2524
Versión
22
Estatus
Active
Clasificación
Test Method
Fecha aprobación
2022-09-01
